Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Finalists of the 2017 Reaxys® PhD Prize Announced

The Reaxys PhD Prize recognizes young chemists conducting original and innovative research in organic, organometallic and inorganic chemistry


News provided by

Elsevier

06 Jul, 2017, 10:01 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 6, 2017 /PRNewswire/ --

Elsevier, the information analytics company specializing in science and health, today announced the 45 finalists for the 2017 Reaxys PhD Prize. Selected from nearly 550 submissions from around the globe, these 45 talented chemists are invited to the Prize Symposium that will be held on October 19 and 20, 2017, in Shanghai.

Launched in 2010, the Reaxys PhD Prize celebrates chemistry PhD students and recent graduates, fostering creativity in ground-breaking chemistry. Besides identifying tomorrow's chemistry leaders, the Prize seeks to empower them to magnify the impact of their work. This starts with the Prize Symposium, where the finalists are provided with an international stage for presenting their research and the opportunity to extend their network with their fellow finalists and internationally recognized chemists.

The 2017 Reaxys PhD Prize Symposium is also the occasion for the Reaxys Advisory Board and Prize coordinators to select the three winners, based on the originality, innovation, relevance and methodological rigor of their presented work. The winners will be announced at the banquet following the Symposium.

The selection of the winners is the last step of a long and rigorous review process. Started in March, the process involved more than 100 international chemists from academia and industry, who, together with Prize Coordinators, are the key to ensure a fair and rigorous selection process.

"As one of the Prize coordinators since 2010, I am very proud to see the continued developed of the Prize. The quality of the submissions is fantastic," said Prof Henry N. C. Wong of the Chinese University of Hong Kong. "I know we will have another difficult but exciting discussion in order to identify this year's winners. I am looking forward to the Symposium in Shanghai and to meeting the finalists in person. Their enthusiasm for their research and for chemistry is one of the most rewarding aspects of the meeting."

This year's 45 finalists are:

  • Ahmed Badran from the Liu group, Harvard University
  • Joshua Barham from the Murphy group, University of Strathclyde
  • Suzanne Batiste from the Johnston group, Vanderbilt University
  • Antonio Bauzá from the Frontera group, University of Balearic Islands
  • Charlotte Boott from the Pringle group, University of Bristol
  • Anna Brezny from the Landis group, University of Wisconsin - Madison
  • Lumen Chao from the Murata group, Kyoto University
  • Zhe Dong from the Dong group, University of Chicago
  • Brendan  Fallon from the Petit group, University Pierre & Marie Curie
  • Alexander Giovannitti from the McCulloch group, Imperial College London
  • Robert Heinze from the Heretsch group, Freie University of Berlin
  • Yoshihiko Iwane from the Suga group, University of Tokyo
  • Xingxing Jiang from the Lin group, University of Chinese Academy of Science
  • Jonathan Kuo from the Norton group, Columbia University
  • Shogo Kuriyama from the Nishibayashi group, University of Tokyo
  • Hiu Lam from the George group, University of Adelaide
  • Matthew Landry from the Burns group, Stanford University
  • Mark Levin from the Toste group, University of California Berkeley
  • Kuangbiao Liao from the Davies group, Emory University
  • Maria Cristina Lo Giudice from the  Dawson group, University College Dublin
  • Moritz Malischewski from the Seppelt group, Freie University of Berlin
  • Koichi Nagata from the Tokitoh group, Kyoto University
  • Takayuki Nakamuro from the Murakami group, Kyoto University
  • Ryo Nakano from the Nozaki group, University of Tokyo
  • Dennis Nielsen from the Skrydstrup group, Aarhus University
  • Keisuke Nogi from the Tsuji group, Kyoto University
  • Jennifer Obligacion from the Chirik group, Princeton University
  • Thomas Osberger from the White group, University of Illinois at Urbana-Champaign
  • Harshkumar Patel from the Sigman group, University of Utah
  • Aleksandra Pekosak from the Windhorst group, Vrije University Medical Center Amsterdam
  • Catherine Pitman from the Miller group, University of North Carolina at Chapel Hill
  • Derrick Roberts from the Nitschke group, University of Cambridge
  • Jessica Rodriguez Villar from the Mascareñas group, University of Santiago de Compostela
  • Koki Sano from the Aida group, University of Tokyo
  • Ryan Schwamm from the Coles group, Victoria University of Wellington
  • Sergii Shylin from the Ksenofontov group, Johannes Gutenberg University of Mainz
  • Markus Suta from the Wickleder group, University of Siegen
  • Andy Thomas from the Denmark group, University of Illinois at Urbana-Champaign
  • Veaceslav Vieru from the Chibotaru group, KU Leuven
  • Fei Wang from the Guosheng Liu group, Shanghai Institute of Organic Chemistry Chinese Academy of Sciences
  • Min Wang from the Wen Liu group, Shanghai Institute of Organic Chemistry Chinese Academy of Sciences
  • Miles White from the Vela group, Iowa State University
  • Kumiko Yamamoto from the Kanai group, University of Tokyo
  • Sui Yang from the Zhang group, University of California Berkeley
  • Changchun Yuan from the Liu group, Sichuan University

Find out more about the Reaxys PhD Prize and Symposium.

Reaxys is a trademark of RELX Intellectual Properties SA, used under license.

About Elsevier  

Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com

Media contact
Christopher Capot
Global Communications, Elsevier
+1-917-704-5174
c.capot@elsevier.com

Modal title

Also from this source

Elsevier launches ScienceDirect AI to transform research with rapid mission-critical insights from trusted content

Elsevier launches ScienceDirect AI to transform research with rapid mission-critical insights from trusted content

Elsevier, a global leader in advanced information and decision support, today launches ScienceDirect AI, a cutting-edge generative AI tool for...

Elsevier Health launches HESI Clinical Practice Readiness Assessment (CPRA): the first assessment of its kind to assess nursing students' practice readiness

Elsevier Health launches HESI Clinical Practice Readiness Assessment (CPRA): the first assessment of its kind to assess nursing students' practice readiness

Elsevier Health, a global leader in medical information and data analytics, today launched HESI Clinical Practice Readiness Assessment (CPRA), the...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.